Tag - pharmaceutical

 
 

PHARMACEUTICAL

A Kobayashi Pharmaceutical factory in Osaka
BUSINESS
Sep 28, 2024
Kobayashi Pharma sued in Taiwan over beni kōji products
A group filed the lawsuit with the Taipei District Court against six firms including a Taiwanese unit of Kobayashi Pharmaceutical and an importer in Taiwan.
Health ministry officials inspect the Wakayama factory of Kobayashi Pharmaceutical in March after reports of health damage surfaced among people who took the firm's red yeast rice supplements.
JAPAN / Science & Health
Sep 18, 2024
Puberulic acid confirmed as source of beni kōji health issues
The substance produced by blue mold was the cause of kidney problems suffered by consumers of the Kobayashi Pharma supplements, the health ministry said.
Officials of the Osaka Municipal Government enter Kobayashi Pharmaceutical's factory, which was closed in December, in the city of Osaka on Tuesday.
JAPAN / Society
Sep 1, 2024
Japan makes supplement health damage reports mandatory
The measure is aimed at enabling administrative authorities to quickly grasp related information and prevent the spread of health damage.
Former Kobayashi Pharmaceutical President Akihiro Kobayashi, currently director in charge of compensation, speaks during a news conference in Osaka earlier this month.
BUSINESS / Companies
Aug 14, 2024
Chinese shoppers’ infatuation with Japanese brands wears thin
The backlash is reminiscent of last year’s outcry over the Fukushima wastewater release
Former Kobayashi Pharmaceutical President Akihiro Kobayashi (second from right) speaks during a news conference in Osaka on Aug. 8 along with President Satoshi Yamane (third from right).
JAPAN / Society
Aug 14, 2024
Kobayashi Pharma fails to report 11 more suspected deaths
The 11 cases had been classified into a wrong category in the process of sorting out the inquiries made to its call center.
Former Kobayashi Pharmaceutical President Akihiro Kobayashi (right) and Satoshi Yamane, the new president, bow in apology over health problems caused by its beni kōji products, during a news conference in the city of Osaka on Thursday.
JAPAN / Science & Health
Aug 8, 2024
Kobayashi Pharma to withdraw from beni kōji product segment
The firm said it would offer compensation to those who suffered health problems linked to their products and prevent a recurrence of the incident.
As of Sunday, Kobayashi Pharmaceutical reported 279 deaths and 2,274 hospital visits due to health issues related to its beni kōji supplements, among which 461 required hospitalization.
JAPAN / Science & Health
Jul 23, 2024
Kobayashi Pharma's president and chairperson resign over health scandal
For the first time in its history, someone outside of the Osaka-based drugmaker's founding family will become its president.
Kobayashi Pharmaceutical President Akihiro Kobayashi and others at a news conference in Osaka in March.
JAPAN / Society
Jul 3, 2024
492 people hospitalized for 'beni kōji' supplements
Kobayashi Pharmaceutical says it has received consultations about a further 170 deaths possibly linked to its supplements.
Health ministry officials enter Kobayashi Pharmaceutical's plant in the city of Osaka on March 30.
JAPAN / Society
Jun 28, 2024
Dozens more deaths may be linked to Kobayashi Pharmaceutical's supplements
The ministry has instructed Kobayashi Pharmaceutical to create a plan to carry out a probe into the causal relationships between the deaths and their products.
Chief Cabinet Secretary Yoshimasa Hayashi (left) addresses a meeting of ministers involved in compiling a policy to revise the system for foods with function claims, held at the Prime Minister's Office on Friday.
JAPAN
May 31, 2024
Japan to overhaul foods with function claims system
The overhaul plan will make it mandatory for companies to promptly report health issues related to foods with function claims to authorities to prevent spread.
Health ministry officials enter Kobayashi Pharmaceutical's plant in the city of Osaka for inspection on March 30.
JAPAN
May 29, 2024
Two more unexpected compounds found in beni kōji supplements
The two compounds are believed to have been created by contamination of blue mold.
A lawyer representing a consumer organization speaks during a meeting held to call for stricter regulations on "functional foods," in Tokyo on Thursday.
JAPAN
May 24, 2024
Mandatory reporting of 'functional food' health problems proposed
The Consumer Affairs Agency panel discussed reforms in response to health problems caused by Kobayashi Pharmaceutical supplement products.
A pack of dietary supplements designated by Kobayashi Pharmaceutical as a functional food.
JAPAN / Science & Health
Apr 30, 2024
Japan panel reviewing 'functional foods' label system
The system has been criticized for leaving it entirely up to functional food makers to guarantee the safety of their products.
Health ministry officials enter Kobayashi Pharmaceutical's factory in the city of Osaka on March 30.
JAPAN / Science & Health
Apr 26, 2024
Kobayashi Pharma to cover bills of people who got ill after taking supplements
The Osaka company’s board has also set up a third-party panel to probe the company’s handling of the issue.
Kobayashi Pharmaceutical's Tokyo office. The company has received 88,000 inquiries about health damage from its supplements.
JAPAN / Science & Health
Apr 20, 2024
More unexpected compounds found in Kobayashi Pharma's beni kōji supplements
At least two compounds not normally found in the supplements were detected in an analysis of ingredient samples.
A survey of the 6,975 products with the functional food label was initiated by the government last month following the scandal over Kobayashi Pharmaceuticals’ beni kōji supplements.
JAPAN / Science & Health
Apr 12, 2024
Probe finds 18 functional food products with past reports of health damage in Japan
The survey results come as the industry reels from deaths linked to Kobayashi Pharmaceutical's beni kōji supplements.
Health experts say the beni kōji supplement scandal should not be treated as a one-off incident. Instead, it should be seen as a cautionary tale about how such health food items could pose more risks than benefits.
JAPAN / Science & Health / FOCUS
Apr 12, 2024
Kobayashi Pharma’s slow response to scandal spotlights deeper issues
Health experts say the scandal should be seen as a cautionary tale, and not a one-off incident.
Kobayashi Pharmaceutical's headquarters in Osaka
JAPAN / Science & Health
Apr 11, 2024
Kobayashi Pharma troubles reverberate in Taiwan as firm assists with recall
Taiwan is the only place outside of Japan to have seen reports of people falling ill after consuming the company's beni kōji.
Health ministry officials head to a Kobayashi Pharmaceutical factory in the city of Osaka on March 30 to conduct a search of the premises.
JAPAN / Science & Health
Apr 9, 2024
Kidney doctors report 95 health complaints linked to beni kōji pills
So far, five people have died, 212 people have been hospitalized and 1,224 others have sought medical treatment after taking the supplements.
A building in Osaka's Chuo Ward housing the Kobayashi Pharmaceutical headquarters
JAPAN / Crime & Legal
Apr 7, 2024
Government holds hearings at Kobayashi Pharmaceutical on supplements
Of those who took the supplements, five people have died and 196 people have been hospitalized so far.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?